Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2002 Aug;78(4):235–240. doi: 10.1136/sti.78.4.235

Sexually acquired hepatitis

M Brook 1
PMCID: PMC1744490  PMID: 12181458

Abstract

Objectives: To assess current knowledge of sexually transmitted viral hepatitis in relation to epidemiology, clinical presentation, management, and diagnosis with particular reference to resource-poor settings.

Method: A search of published literature identified through Medline from 1966 to October 2001, the Cochrane Library, and reference lists taken from each article obtained. Textword and MeSH searches for hepatitis A, B, C, D, E, G, delta, GB virus, GBV-C, and TT virus were linked to searches under the textword terms sex$, prevent$, and MeSH subheadings, microbiology, complications, drug therapy, therapy, diagnosis, epidemiology, transmission, and prevention and control.

Conclusions: In heterosexual relationships, hepatitis B is readily transmitted sexually and hepatitis C and D less so, with no evidence for sexual transmission of hepatitis A. Hepatitis types A‘D are all transmissible sexually in male homosexual relationships under certain conditions. In resource-poor countries sexual transmission is generally only a significant route of transmission for hepatitis B.

Full Text

The Full Text of this article is available as a PDF (154.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Hadler S. C., Margolis H. S., Alexander W. J., Hu P. Y., Judson F. N., Mares A., Miller J. K., Moyer L. A. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990 Mar 2;263(9):1218–1222. [PubMed] [Google Scholar]
  2. Badur S., Akgün A. Diagnosis of hepatitis B infections and monitoring of treatment. J Clin Virol. 2001 Jun;21(3):229–237. doi: 10.1016/s1386-6532(01)00147-0. [DOI] [PubMed] [Google Scholar]
  3. Bhave G., Lindan C. P., Hudes E. S., Desai S., Wagle U., Tripathi S. P., Mandel J. S. Impact of an intervention on HIV, sexually transmitted diseases, and condom use among sex workers in Bombay, India. AIDS. 1995 Jul;9 (Suppl 1):S21–S30. [PubMed] [Google Scholar]
  4. Bratòs M. A., Eiros J. M., Orduña A., Cuervo M., Ortiz de Lejarazu R., Almaraz A., Martín-Rodríguez J. F., Gutiérrez-Rodríguez M. P., Orduña Prieto E., Rodríguez-Torres A. Influence of syphilis in hepatitis B transmission in a cohort of female prostitutes. Sex Transm Dis. 1993 Sep-Oct;20(5):257–261. doi: 10.1097/00007435-199309000-00003. [DOI] [PubMed] [Google Scholar]
  5. Brook M. G., Chan G., Yap I., Karayiannis P., Lever A. M., Jacyna M., Main J., Thomas H. C. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ. 1989 Sep 9;299(6700):652–656. doi: 10.1136/bmj.299.6700.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chiaramonte M., Stroffolini T., Vian A., Stazi M. A., Floreani A., Lorenzoni U., Lobello S., Farinati F., Naccarato R. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer. 1999 May 15;85(10):2132–2137. [PubMed] [Google Scholar]
  7. Chu C. M., Yeh C. T., Liaw Y. F. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut. 1999 Oct;45(4):613–617. doi: 10.1136/gut.45.4.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chudy M., Budek I., Keller-Stanislawski B., McCaustland K. A., Neidhold S., Robertson B. H., Nübling C. M., Seitz R., Löwer J. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool. J Med Virol. 1999 Feb;57(2):91–99. doi: 10.1002/(sici)1096-9071(199902)57:2<91::aid-jmv1>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  9. Coleman J. C., Waugh M., Dayton R. Hepatitis B antigen and antibody in a male homosexual population. Br J Vener Dis. 1977 Apr;53(2):132–134. doi: 10.1136/sti.53.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Colin J. F., Cazals-Hatem D., Loriot M. A., Martinot-Peignoux M., Pham B. N., Auperin A., Degott C., Benhamou J. P., Erlinger S., Valla D. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999 Apr;29(4):1306–1310. doi: 10.1002/hep.510290447. [DOI] [PubMed] [Google Scholar]
  11. Corona R., Stroffolini T., Giglio A., Cotichini R., Tosti M. E., Prignano G., Di Carlo A., Maini A., Mele A. Lack of evidence for increased risk of hepatitis A infection in homosexual men. Epidemiol Infect. 1999 Aug;123(1):89–93. doi: 10.1017/s0950268899002678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coutinho R. A., Schut B. J., Albrecht-Van Lent N. A., Reerink-Brongers E. E., Jesdijk L. S. Hepatitis B among homosexual men in The Netherlands. Sex Transm Dis. 1981 Oct-Dec;8(4 Suppl):333–335. [PubMed] [Google Scholar]
  13. Das K., Jain A., Gupta S., Kapoor S., Gupta R. K., Chakravorty A., Kar P. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol. 2000 Jun;16(6):507–510. doi: 10.1023/a:1007628021661. [DOI] [PubMed] [Google Scholar]
  14. Dienstag J. L., Schiff E. R., Wright T. L., Perrillo R. P., Hann H. W., Goodman Z., Crowther L., Condreay L. D., Woessner M., Rubin M. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med. 1999 Oct 21;341(17):1256–1263. doi: 10.1056/NEJM199910213411702. [DOI] [PubMed] [Google Scholar]
  15. Dienstag J. L. Sexual and perinatal transmission of hepatitis C. Hepatology. 1997 Sep;26(3 Suppl 1):66S–70S. doi: 10.1002/hep.510260712. [DOI] [PubMed] [Google Scholar]
  16. Dore G. J., Cooper D. A., Barrett C., Goh L. E., Thakrar B., Atkins M. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee. J Infect Dis. 1999 Sep;180(3):607–613. doi: 10.1086/314942. [DOI] [PubMed] [Google Scholar]
  17. Fagan E. A., Williams R. Fulminant viral hepatitis. Br Med Bull. 1990 Apr;46(2):462–480. doi: 10.1093/oxfordjournals.bmb.a072410. [DOI] [PubMed] [Google Scholar]
  18. Fathalla S. E., Al-Jama A. A., Al-Sheikh I. H., Islam S. I. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J. 2000 Oct;21(10):945–949. [PubMed] [Google Scholar]
  19. Fattovich G., Giustina G., Christensen E., Pantalena M., Zagni I., Realdi G., Schalm S. W. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut. 2000 Mar;46(3):420–426. doi: 10.1136/gut.46.3.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Feldman J. G., Minkoff H., Landesman S., Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis. 2000 Jul;27(6):338–342. doi: 10.1097/00007435-200007000-00007. [DOI] [PubMed] [Google Scholar]
  21. Flodgren E., Bengtsson S., Knutsson M., Strebkova E. A., Kidd A. H., Alexeyev O. A., Kidd-Ljunggren K. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol. 2000 Sep;38(9):3311–3316. doi: 10.1128/jcm.38.9.3311-3316.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Francis D. P., Hadler S. C., Thompson S. E., Maynard J. E., Ostrow D. G., Altman N., Braff E. H., O'Malley P., Hawkins D., Judson F. N. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982 Sep;97(3):362–366. doi: 10.7326/0003-4819-97-3-362. [DOI] [PubMed] [Google Scholar]
  23. Gilson R. J., de Ruiter A., Waite J., Ross E., Loveday C., Howell D. R., Tedder R. S., Weller I. V. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Transm Infect. 1998 Apr;74(2):110–115. doi: 10.1136/sti.74.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gitlin N. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem. 1997 Aug;43(8 Pt 2):1500–1506. [PubMed] [Google Scholar]
  25. Goldberg D., McIntyre P. G., Smith R., Appleyard K., Dunlop J., Taylor A., Hutchinson S. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. BJOG. 2001 Apr;108(4):365–370. doi: 10.1111/j.1471-0528.2001.00089.x. [DOI] [PubMed] [Google Scholar]
  26. Gretch D. R. Diagnostic tests for hepatitis C. Hepatology. 1997 Sep;26(3 Suppl 1):43S–47S. doi: 10.1002/hep.510260708. [DOI] [PubMed] [Google Scholar]
  27. Grinde B., Stene-Johansen K., Sharma B., Hoel T., Jensenius M., Skaug K. Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers--infection by needle sharing? J Med Virol. 1997 Sep;53(1):69–75. doi: 10.1002/(sici)1096-9071(199709)53:1<69::aid-jmv12>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  28. Habib M., Mohamed M. K., Abdel-Aziz F., Magder L. S., Abdel-Hamid M., Gamil F., Madkour S., Mikhail N. N., Anwar W., Strickland G. T. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology. 2001 Jan;33(1):248–253. doi: 10.1053/jhep.2001.20797. [DOI] [PubMed] [Google Scholar]
  29. Hart G. J., Dawson J., Fitzpatrick R. M., Boulton M., McLean J., Brookes M., Parry J. V. Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England, 1991-1992. AIDS. 1993 Jun;7(6):863–869. doi: 10.1097/00002030-199306000-00016. [DOI] [PubMed] [Google Scholar]
  30. Henning K. J., Bell E., Braun J., Barker N. D. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am J Med. 1995 Aug;99(2):132–136. doi: 10.1016/s0002-9343(99)80132-6. [DOI] [PubMed] [Google Scholar]
  31. Hoofnagle J. H. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997 Sep;26(3 Suppl 1):15S–20S. doi: 10.1002/hep.510260703. [DOI] [PubMed] [Google Scholar]
  32. Huang K., Lin S. Nationwide vaccination: a success story in Taiwan. Vaccine. 2000 Feb 18;18 (Suppl 1):S35–S38. doi: 10.1016/s0264-410x(99)00460-0. [DOI] [PubMed] [Google Scholar]
  33. Hyams K. C., Krogwold R. A., Brock S., Wignall F. S., Cross E., Hayes C. Heterosexual transmission of viral hepatitis and cytomegalovirus infection among United States military personnel stationed in the western Pacific. Sex Transm Dis. 1993 Jan-Feb;20(1):36–40. doi: 10.1097/00007435-199301000-00007. [DOI] [PubMed] [Google Scholar]
  34. Hyams K. C., Phillips I. A., Tejada A., Li O., Hermoza P., Lopez F., Alva P., Chauca G., Sanchez S., Wignall F. S. Hepatitis B in a highly active prostitute population: evidence for a low risk of chronic antigenemia. J Infect Dis. 1990 Aug;162(2):295–298. doi: 10.1093/infdis/162.2.295. [DOI] [PubMed] [Google Scholar]
  35. Hyams K. C., Phillips I. A., Tejada A., Wignall F. S., Roberts C. R., Escamilla J. Three-year incidence study of retroviral and viral hepatitis transmission in a Peruvian prostitute population. J Acquir Immune Defic Syndr. 1993 Dec;6(12):1353–1357. [PubMed] [Google Scholar]
  36. Hyams K. C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995 Apr;20(4):992–1000. doi: 10.1093/clinids/20.4.992. [DOI] [PubMed] [Google Scholar]
  37. Jacobs B., Mayaud P., Changalucha J., Todd J., Ka-Gina G., Grosskurth H., Berege Z. A. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis. 1997 Mar;24(3):121–126. doi: 10.1097/00007435-199703000-00001. [DOI] [PubMed] [Google Scholar]
  38. Janssen H. L., Gerken G., Carreño V., Marcellin P., Naoumov N. V., Craxi A., Ring-Larsen H., Kitis G., van Hattum J., de Vries R. A. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology. 1999 Jul;30(1):238–243. doi: 10.1002/hep.510300113. [DOI] [PubMed] [Google Scholar]
  39. Katz M. H., Hsu L., Wong E., Liska S., Anderson L., Janssen R. S. Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. J Infect Dis. 1997 May;175(5):1225–1229. doi: 10.1086/593675. [DOI] [PubMed] [Google Scholar]
  40. Keeffe E. B. Clinical approach to viral hepatitis in homosexual men. Med Clin North Am. 1986 May;70(3):567–586. doi: 10.1016/s0025-7125(16)30940-3. [DOI] [PubMed] [Google Scholar]
  41. Kura M. M., Hira S., Kohli M., Dalal P. J., Ramnani V. K., Jagtap M. R. High occurrence of HBV among STD clinic attenders in Bombay, India. Int J STD AIDS. 1998 Apr;9(4):231–233. doi: 10.1258/0956462981921954. [DOI] [PubMed] [Google Scholar]
  42. Leentvaar-Kuijpers A., Kool J. L., Veugelers P. J., Coutinho R. A., van Griensven G. J. An outbreak of hepatitis A among homosexual men in Amsterdam, 1991-1993. Int J Epidemiol. 1995 Feb;24(1):218–222. doi: 10.1093/ije/24.1.218. [DOI] [PubMed] [Google Scholar]
  43. Liaw Y. F., Chiu K. W., Chu C. M., Sheen I. S., Huang M. J. Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J Infect Dis. 1990 Nov;162(5):1170–1172. doi: 10.1093/infdis/162.5.1170. [DOI] [PubMed] [Google Scholar]
  44. Lin S. M., Sheen I. S., Chien R. N., Chu C. M., Liaw Y. F. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology. 1999 Mar;29(3):971–975. doi: 10.1002/hep.510290312. [DOI] [PubMed] [Google Scholar]
  45. Luksamijarulkul P., Khemnak P., Pacheun O. Human immunodeficiency virus and hepatitis C virus infections among patients attending sexually transmitted disease clinics, Regional 2, Thailand. Asia Pac J Public Health. 2000;12(1):41–45. doi: 10.1177/101053950001200109. [DOI] [PubMed] [Google Scholar]
  46. Maida M. J., Daly C. C., Hoffman I., Cohen M. S., Kumwenda M., Vernazza P. L. Prevalence of hepatitis C infection in Malawi and lack of association with sexually transmitted diseases. Eur J Epidemiol. 2000;16(12):1183–1184. doi: 10.1023/a:1010920426795. [DOI] [PubMed] [Google Scholar]
  47. Main J., Brown J. L., Howells C., Galassini R., Crossey M., Karayiannis P., Georgiou P., Atkinson G., Thomas H. C. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepat. 1996 Jul;3(4):211–215. doi: 10.1111/j.1365-2893.1996.tb00098.x. [DOI] [PubMed] [Google Scholar]
  48. Manns M. P., McHutchison J. G., Gordon S. C., Rustgi V. K., Shiffman M., Reindollar R., Goodman Z. D., Koury K., Ling M., Albrecht J. K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001 Sep 22;358(9286):958–965. doi: 10.1016/s0140-6736(01)06102-5. [DOI] [PubMed] [Google Scholar]
  49. Manock S. R., Kelley P. M., Hyams K. C., Douce R., Smalligan R. D., Watts D. M., Sharp T. W., Casey J. L., Gerin J. L., Engle R. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):209–213. doi: 10.4269/ajtmh.2000.63.209. [DOI] [PubMed] [Google Scholar]
  50. Matee M. I., Lyamuya E. F., Mbena E. C., Magessa P. M., Sufi J., Marwa G. J., Mwasulama O. J., Mbwana J. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. East Afr Med J. 1999 Mar;76(3):167–171. [PubMed] [Google Scholar]
  51. McIntyre N. Clinical presentation of acute viral hepatitis. Br Med Bull. 1990 Apr;46(2):533–547. doi: 10.1093/oxfordjournals.bmb.a072414. [DOI] [PubMed] [Google Scholar]
  52. McIntyre N. Clinical presentation of acute viral hepatitis. Br Med Bull. 1990 Apr;46(2):533–547. doi: 10.1093/oxfordjournals.bmb.a072414. [DOI] [PubMed] [Google Scholar]
  53. McPherson R. A. Laboratory diagnosis of human hepatitis viruses. J Clin Lab Anal. 1994;8(6):369–377. doi: 10.1002/jcla.1860080606. [DOI] [PubMed] [Google Scholar]
  54. Mele A., Franco E., Caprilli F., Gentili G., Stazi M. A., Zaratti L., Capitanio B., Crescimbeni E., Corona R., Panà A. Hepatitis B and Delta virus infection among heterosexuals, homosexuals and bisexual men. Eur J Epidemiol. 1988 Dec;4(4):488–491. doi: 10.1007/BF00146404. [DOI] [PubMed] [Google Scholar]
  55. Minuk G. Y., Ding L. X., Hannon C., Sekla L. The risks of transmission of acute hepatitis A and B virus infection in an urban centre. J Hepatol. 1994 Jul;21(1):118–121. doi: 10.1016/s0168-8278(94)80147-9. [DOI] [PubMed] [Google Scholar]
  56. Modahl L. E., Lai M. M. Hepatitis delta virus: the molecular basis of laboratory diagnosis. Crit Rev Clin Lab Sci. 2000 Feb;37(1):45–92. doi: 10.1080/10408360091174178. [DOI] [PubMed] [Google Scholar]
  57. Nandwani R., Caswell S., Boag F., Lawrence A. G., Coleman J. C. Hepatitis A seroprevalence in homosexual and heterosexual men. Genitourin Med. 1994 Oct;70(5):325–328. doi: 10.1136/sti.70.5.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. National guideline for the management of the viral hepatitides A, B, and C. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect. 1999 Aug;75 (Suppl 1):S57–S64. [PubMed] [Google Scholar]
  59. Niro G. A., Casey J. L., Gravinese E., Garrubba M., Conoscitore P., Sagnelli E., Durazzo M., Caporaso N., Perri F., Leandro G. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol. 1999 Apr;30(4):564–569. doi: 10.1016/s0168-8278(99)80185-8. [DOI] [PubMed] [Google Scholar]
  60. Oliveira L. H., Silva I. R., Xavier B. L., Cavalcanti S. M. Hepatitis B infection among patients attending a sexually transmitted diseases clinic in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2001 Jul;96(5):635–640. doi: 10.1590/s0074-02762001000500007. [DOI] [PubMed] [Google Scholar]
  61. Oliveira M. L., Bastos F. I., Telles P. R., Yoshida C. F., Schatzmayr H. G., Paetzold U., Pauli G., Schreier E. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res. 1999 Sep;32(9):1107–1114. doi: 10.1590/S0100-879X1999000900009. [DOI] [PubMed] [Google Scholar]
  62. Osella A. R., Massa M. A., Joekes S., Blanch N., Yacci M. R., Centonze S., Sileoni S. Hepatitis B and C virus sexual transmission among homosexual men. Am J Gastroenterol. 1998 Jan;93(1):49–52. doi: 10.1111/j.1572-0241.1998.049_c.x. [DOI] [PubMed] [Google Scholar]
  63. Polish L. B., Robertson B. H., Khanna B., Krawczynski K., Spelbring J., Olson F., Shapiro C. N. Excretion of hepatitis A virus (HAV) in adults: comparison of immunologic and molecular detection methods and relationship between HAV positivity and infectivity in tamarins. J Clin Microbiol. 1999 Nov;37(11):3615–3617. doi: 10.1128/jcm.37.11.3615-3617.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Polz-Dacewicz M. A., Policzkiewicz P., Badach Z. Changing epidemiology of hepatitis A virus infection--a comparative study in central eastern Poland (1990-1999). Med Sci Monit. 2000 Sep-Oct;6(5):989–993. [PubMed] [Google Scholar]
  65. Rodríguez L., Collado-Mesa F., Aragón U., Díaz B., Rivero J. Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients. Mem Inst Oswaldo Cruz. 2000 Mar-Apr;95(2):243–245. doi: 10.1590/s0074-02762000000200019. [DOI] [PubMed] [Google Scholar]
  66. Sagliocca L., Amoroso P., Stroffolini T., Adamo B., Tosti M. E., Lettieri G., Esposito C., Buonocore S., Pierri P., Mele A. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet. 1999 Apr 3;353(9159):1136–1139. doi: 10.1016/S0140-6736(98)08139-2. [DOI] [PubMed] [Google Scholar]
  67. Sciot R., Van Damme B., Desmet V. J. Cholestatic features in hepatitis A. J Hepatol. 1986;3(2):172–181. doi: 10.1016/s0168-8278(86)80023-x. [DOI] [PubMed] [Google Scholar]
  68. Seage G. R., 3rd, Mayer K. H., Lenderking W. R., Wold C., Gross M., Goldstein R., Cai B., Heeren T., Hingson R., Holmberg S. HIV and hepatitis B infection and risk behavior in young gay and bisexual men. Public Health Rep. 1997 Mar-Apr;112(2):158–167. [PMC free article] [PubMed] [Google Scholar]
  69. Seeff L. B. Natural history of hepatitis C. Hepatology. 1997 Sep;26(3 Suppl 1):21S–28S. doi: 10.1002/hep.510260704. [DOI] [PubMed] [Google Scholar]
  70. Shapiro C. N., Margolis H. S. Worldwide epidemiology of hepatitis A virus infection. J Hepatol. 1993;18 (Suppl 2):S11–S14. doi: 10.1016/s0168-8278(05)80371-x. [DOI] [PubMed] [Google Scholar]
  71. Shaw D. D., Whiteman D. C., Merritt A. D., el-Saadi D. M., Stafford R. J., Heel K., Smith G. A. Hepatitis A outbreaks among illicit drug users and their contacts in Queensland, 1997. Med J Aust. 1999 Jun 21;170(12):584–587. doi: 10.5694/j.1326-5377.1999.tb127904.x. [DOI] [PubMed] [Google Scholar]
  72. Singh J., Gupta S., Khare S., Bhatia R., Jain D. C., Sokhey J. A severe and explosive outbreak of hepatitis B in a rural population in Sirsa district, Haryana, India: unnecessary therapeutic injections were a major risk factor. Epidemiol Infect. 2000 Dec;125(3):693–699. doi: 10.1017/s0950268800004684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Smikle M., Dowe G., Hylton-Kong T., Williams E. Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica. Sex Transm Infect. 2001 Aug;77(4):295–296. doi: 10.1136/sti.77.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Smith H. M., Alexander G. J., Webb G., McManus T., McFarlane I. G., Williams R. Hepatitis B and delta virus infection among "at risk" populations in south east London. J Epidemiol Community Health. 1992 Apr;46(2):144–147. doi: 10.1136/jech.46.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Soucie J. M., Robertson B. H., Bell B. P., McCaustland K. A., Evatt B. L. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Transfusion. 1998 Jun;38(6):573–579. doi: 10.1046/j.1537-2995.1998.38698326337.x. [DOI] [PubMed] [Google Scholar]
  76. Stapleton J. T. Host immune response to hepatitis A virus. J Infect Dis. 1995 Mar;171 (Suppl 1):S9–14. doi: 10.1093/infdis/171.supplement_1.s9. [DOI] [PubMed] [Google Scholar]
  77. Stene-Johansen K., Skaug K., Blystad H., Grinde B. A unique hepatitis A virus strain caused an epidemic in Norway associated with intravenous drug abuse. The Hepatitis A Study Group. Scand J Infect Dis. 1998;30(1):35–38. doi: 10.1080/003655498750002277. [DOI] [PubMed] [Google Scholar]
  78. Stewart T., Crofts N. An outbreak of hepatitis A among homosexual men in Melbourne. Med J Aust. 1993 Apr 19;158(8):519–521. doi: 10.5694/j.1326-5377.1993.tb121865.x. [DOI] [PubMed] [Google Scholar]
  79. Struve J., Giesecke J., Lindh G., Weiland O. Heterosexual contact as a major route for transmission of acute hepatitis B among adults. J Infect. 1990 Mar;20(2):111–121. doi: 10.1016/0163-4453(90)93288-4. [DOI] [PubMed] [Google Scholar]
  80. Sun C. A., Chen H. C., Lu S. N., Chen C. J., Lu C. F., You S. L., Lin S. H. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol. 2001 Sep;65(1):30–34. [PubMed] [Google Scholar]
  81. Sundkvist T., Aitken C., Duckworth G., Jeffries D. Outbreak of acute hepatitis A among homosexual men in East London. Scand J Infect Dis. 1997;29(3):211–212. doi: 10.3109/00365549709019028. [DOI] [PubMed] [Google Scholar]
  82. Szmuness W., Much I., Prince A. M., Hoofnagle J. H., Cherubin C. E., Harley E. J., Block G. H. On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med. 1975 Oct;83(4):489–495. doi: 10.7326/0003-4819-83-4-489. [DOI] [PubMed] [Google Scholar]
  83. Szmuness W., Stevens C. E., Zang E. A., Harley E. J., Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981 Sep-Oct;1(5):377–385. doi: 10.1002/hep.1840010502. [DOI] [PubMed] [Google Scholar]
  84. Takechi A., Hatakeyama S., Kashiyama T., Koibuchi T. [Outbreak of hepatitis A virus infection among men who have sex with men]. Kansenshogaku Zasshi. 2000 Sep;74(9):716–719. doi: 10.11150/kansenshogakuzasshi1970.74.716. [DOI] [PubMed] [Google Scholar]
  85. Tsiang M., Rooney J. F., Toole J. J., Gibbs C. S. Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology. 1999 Jun;29(6):1863–1869. doi: 10.1002/hep.510290626. [DOI] [PubMed] [Google Scholar]
  86. Van Damme P., Cramm M., Van der Auwera J. C., Vranckx R., Meheus A. Horizontal transmission of hepatitis B virus. Lancet. 1995 Jan 7;345(8941):27–29. doi: 10.1016/s0140-6736(95)91155-3. [DOI] [PubMed] [Google Scholar]
  87. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., Ferraro T., Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998 Jan 29;338(5):286–290. doi: 10.1056/NEJM199801293380503. [DOI] [PubMed] [Google Scholar]
  88. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., Ferraro T., Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998 Jan 29;338(5):286–290. doi: 10.1056/NEJM199801293380503. [DOI] [PubMed] [Google Scholar]
  89. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., Ferraro T., Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998 Jan 29;338(5):286–290. doi: 10.1056/NEJM199801293380503. [DOI] [PubMed] [Google Scholar]
  90. Villano S. A., Nelson K. E., Vlahov D., Purcell R. H., Saah A. J., Thomas D. L. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis. 1997 Sep;25(3):726–728. doi: 10.1086/513757. [DOI] [PubMed] [Google Scholar]
  91. Willner I. R., Uhl M. D., Howard S. C., Williams E. Q., Riely C. A., Waters B. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med. 1998 Jan 15;128(2):111–114. doi: 10.7326/0003-4819-128-2-199801150-00006. [DOI] [PubMed] [Google Scholar]
  92. Winokur P. L., Stapleton J. T. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis. 1992 Feb;14(2):580–586. doi: 10.1093/clinids/14.2.580. [DOI] [PubMed] [Google Scholar]
  93. Yao G. B. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38 (Suppl 2):S39–S42. doi: 10.1136/gut.38.suppl_2.s39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Yao G. B. Management of hepatitis B in China. J Med Virol. 2000 Jul;61(3):392–397. doi: 10.1002/1096-9071(200007)61:3<392::aid-jmv19>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  95. Zarski J. P., Bohn B., Bastie A., Pawlotsky J. M., Baud M., Bost-Bezeaux F., Tran van Nhieu J., Seigneurin J. M., Buffet C., Dhumeaux D. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol. 1998 Jan;28(1):27–33. doi: 10.1016/s0168-8278(98)80198-0. [DOI] [PubMed] [Google Scholar]
  96. Zhao S., Xu Z., Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. Int J Epidemiol. 2000 Aug;29(4):744–752. doi: 10.1093/ije/29.4.744. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES